EQS-News: Viromed Medical AG / Key word(s): Market LaunchViromed Medical AG: Successful ISO 13485 certification paves the way for market launch of ViroCAP® in October 202518.09.2025 / 10:23 CET/CESTThe issuer is solely responsible for the content of this announcement. Viromed Medical AG: Successful ISO 13485 certification paves the way for market launch of ViroCAP® in October 2025Rellingen, September 18, 2025 – Viromed Medical AG ("Viromed"; ISIN: DE000A3MQR65), a medical technology company and pioneer of cold plasma technology, has received the ISO 13485 certification. Viromed can now independently approve and market ViroCAP®, a mobile medical device for the treatment of skin diseases. Uwe Perbandt, CEO of Viromed Medical AG, explains: "With this certification, we have reached the next milestone. About Viromed Medical AGViromed Medical AG specializes in the development, manufacture and distribution of medical products.